Evidence map›Paper›PMID 26021852›Full record

ArticleLab on a chip2015

Well plate-based perfusion culture device for tissue and tumor microenvironment replication.

W Zhang, Y Gu, Y Hao, Q Sun, K Konior, H Wang, J Zilberberg, W Y Lee

Abstract read
In one paragraph

Article in Lab on a chip, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Biomedical materials (Bristol, England) · 2022
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

W ZhangDepartment of Chemical Engineering and Materials Science, Stevens Institute of Technology, 1 Castle Point on Hudson, Hoboken, NJ, 07030, USA.
Y GuDepartment of Chemical Engineering and Materials Science, Stevens Institute of Technology, 1 Castle Point on Hudson, Hoboken, NJ, 07030, USA.
Y HaoDepartment of Chemical Engineering and Materials Science, Stevens Institute of Technology, 1 Castle Point on Hudson, Hoboken, NJ, 07030, USA.
Q SunDepartment of Chemical Engineering and Materials Science, Stevens Institute of Technology, 1 Castle Point on Hudson, Hoboken, NJ, 07030, USA.
K KoniorDepartment of Chemical Engineering and Materials Science, Stevens Institute of Technology, 1 Castle Point on Hudson, Hoboken, NJ, 07030, USA.
H WangDepartment of Chemistry, Chemical Biology, and Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.
J Zilberberg *Research Department, Hackensack University Medical Center, 40 Prospect Ave, Hackensack, NJ, 07601, USA.
W Y Lee *Department of Chemical Engineering and Materials Science, Stevens Institute of Technology, 1 Castle Point on Hudson, Hoboken, NJ, 07030, USA.

Funding

Microfluidic approach for the development of a three-dimensional bone marrow micrR21CA174543 · NCI · HACKENSACK UNIVERSITY MEDICAL CENTER · PI LEE, WOO YOUNG, ZILBERBERG, JENNY · 2014 to 2016
$686k
Microfluidic 3D Culture of Primary OsteocytesR21AR065032 · NIAMS · THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY · PI LEE, WOO YOUNG · 2013 to 2014
$348k
NCI NIH HHS R21 CA174543NIAMS NIH HHS 1R21AR065032NIAMS NIH HHS R21 AR065032
6 · The paper itself

Abstract

There are significant challenges in developing in vitro human tissue and tumor models that can be used to support new drug development and evaluate personalized therapeutics. The challenges include: (1) working with primary cells which are often difficult to maintain ex vivo, (2) mimicking native microenvironments from which primary cells are harvested, and (3) the lack of culture devices that can support these microenvironments to evaluate drug responses in a high-throughput manner. Here we report a versatile well plate-based perfusion culture device that was designed, fabricated and used to: (1) ascertain the role of perfusion in facilitating the expansion of human multiple myeloma cells and evaluate drug response of the cells, (2) preserve the physiological phenotype of primary murine osteocytes by reconstructing the 3D cellular network of osteocytes, and (3) circulate primary murine T cells through a layer of primary murine intestine epithelial cells to recapitulate the interaction of the immune cells with the epithelial cells. Through these diverse case studies, we demonstrate the device's design features to support: (1) the convenient and spatiotemporal placement of cells and biomaterials into the culture wells of the device; (2) the replication of tissues and tumor microenvironments using perfusion, stromal cells, and/or biomaterials; (3) the circulation of non-adherent cells through the culture chambers; and (4) conventional tissue and cell characterization by plate reading, histology, and flow cytometry. Future challenges are identified and discussed from the perspective of manufacturing the device and making its operation for routine and wide use.

Indexed as

AnimalsAntineoplastic AgentsBiocompatible MaterialsCell Culture TechniquesCell LineHumansMiceMicrofluidic Analytical TechniquesModels, BiologicalMultiple MyelomaOligopeptidesOsteocytesStromal CellsTumor MicroenvironmentAntineoplastic AgentsBiocompatible MaterialscarfilzomibOligopeptides

Identifiers

PMID26021852
PMCPMC4470735

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.